Authors: KOWOLENKO M IRWIN R WROBLEWSKI V

Citation: M. Kowolenko et al., PRECLINICAL EVALUATION OF AN IMPROVED FORMULATION OF HUMAN RECOMBINANT FVIII (KOGENATE-2) - TOXICOLOGY, PHARMACOLOGY, PHARMACOKINETICS, ANDNEOANTIGENICITY, Thrombosis and haemostasis, 1997, pp. 2084-2084

Authors: BROWN JE WROBLEWSKI V MASNYK M HARRISON J JARVIS M

Citation: Je. Brown et al., PHARMACOKINETIC MEASUREMENTS OF HUMAN FVIII IN NON-HEMOPHILIC ANIMALS, Thrombosis and haemostasis, 73(6), 1995, pp. 1212-1212